FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Levofloxacin (LEVAQUIN) Oral Solution
Status: Discontinuation
»Therapeutic Categories:

Expand all

Janssen Pharmaceuticals (New 06/30/2014)

Company Contact Information:
800-526-7736

Presentation Posting Date Related Information
Levofloxacin Oral Solution 25 mg/mL 06/30/2014 Janssen Pharmaceuticals has made a business decision to permanently discontinue LEVAQUIN (levofloxacin Oral Solution 25 mg/mL and Levofloxacin Oral Solution 25 mg/mL (Authorized Generic). Product should be maintained on the formularies until the last batch produced expires (April 30, 2015), in order to maintain continuity of the reimbursement process.

Patriot Pharmaceuticals (New 06/30/2014)

Company Contact Information:
800-667-8570

Presentation Posting Date Related Information
Levofloxacin Oral Solution 25 mg/mL 06/30/2014 Janssen Pharmaceuticals has made a business decision to permanently discontinue LEVAQUIN (levofloxacin Oral Solution 25 mg/mL and Levofloxacin Oral Solution 25 mg/mL (Authorized Generic). Product should be maintained on the formularies until the last batch produced expires (April 30, 2015), in order to maintain continuity of the reimbursement process.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English